Back to 
CLIFFORD SWAN INVESTMENT COUNSEL LLC
CLIFFORD SWAN INVESTMENT COUNSEL LLC
ARWR
Showing 0 of 5 quarters
Position history for CLIFFORD SWAN INVESTMENT COUNSEL LLC's holdings in ARROWHEAD PHARMACEUTICALS IN
No. Clifford Swan Investment Counsel exited its ARWR (Arrowhead Pharmaceuticals in) position in Q1 2020. Its Q4 2019 13F listed 21,408 shares worth $1.4M. Clifford Swan Investment Counsel already held ARWR in its Q1 2019 13F, the earliest on record, and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.